Healthcare Realty Trust (HR) Receives a New Rating from Wedbush
Wedbush analyst Richard Anderson initiated coverage with a Buy rating on Healthcare Realty Trust on September 30 and set a price target of $23.00. The company’s shares closed yesterday at $18.37.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Anderson covers the Real Estate sector, focusing on stocks such as AvalonBay, Douglas Emmett, and Safehold. According to TipRanks, Anderson has an average return of 8.4% and a 68.31% success rate on recommended stocks.
Currently, the analyst consensus on Healthcare Realty Trust is a Hold with an average price target of $19.33, implying a 5.23% upside from current levels. In a report released on September 29, BTIG also maintained a Buy rating on the stock with a $20.00 price target.
The company has a one-year high of $18.82 and a one-year low of $14.09. Currently, Healthcare Realty Trust has an average volume of 3.97M.
Based on the recent corporate insider activity of 42 insiders, corporate insider sentiment is neutral on the stock.
Read More on HR:
Disclaimer & DisclosureReport an Issue
- Healthcare Realty Trust initiated with an Overweight at Cantor Fitzgerald
- Healthcare Realty Trust management to meet with BTIG
- Broadcom initiated, Beyond Meat downgraded: Wall Street’s top analyst calls
- Healthcare Realty Trust downgraded to Underperform at Raymond James
- Lululemon downgraded, Samsara upgraded: Wall Street’s top analyst calls
